Saline in acute bronchiolitis RCT and economic evaluation: Hypertonic saline in acute bronchiolitis – Randomised controlled trial and systematic review

Health Technology Assessment

Volumn 19, Issue 66, 2015, Pages 1-130

  Everard, Mark L ^a   Hind, Daniel ^b   Ugonna, Kelechi ^c   Freeman, Jennifer ^d   Bradburn, Mike ^b   Dixon, Simon ^b   Maguire, Chin ^b   Cantrill, Hannah ^b   Alexander, John ^e   Lenney, Warren ^f   McNamara, Paul ^g   Elphick, Heather ^c   Chetcuti, Philip A J ^h   Moya, Eduardo F ⁱ   Powell, Colin ^j   Garside, Jonathan P ^k   Chadha, Lavleen Kumar ^l   Kurian, Matthew ^l   Lehal, Ravinderjit S ^m   MacFarlane, Peter I ⁿ   Cooper, Cindy L ^b   Cross, Elizabeth ^b   more..

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c SHEFFIELD CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e UNIVERSITY HOSPITALS OF NORTH MIDLANDS NHS TRUST   (United Kingdom)

^f KEELE UNIVERSITY   (United Kingdom)

^g UNIVERSITY OF LIVERPOOL   (United Kingdom)

^h LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

ⁱ BRADFORD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^j UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^k CALDERDALE AND HUDDERSFIELD NHS FOUNDATION TRUST   (United Kingdom)

^l Doncaster and Bassetlaw Hospitals NHS Foundation Trust   (United Kingdom)

^m OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

ⁿ Rotherham NHS Foundation Trust   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMBROXOL; BRONCHODILATING AGENT; SALBUTAMOL; SODIUM CHLORIDE;

ACUTE BRONCHIOLITIS; ACUTE DISEASE; APNEA; ARTICLE; BACTERIAL INFECTION; BRADYCARDIA; BREATHING RATE; BRONCHIOLITIS; CHEST INFECTION; CHICKENPOX; CLINICAL EFFECTIVENESS; CONJUNCTIVITIS; CONSTIPATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; COUGHING; DISEASE SEVERITY; DYSPNEA; FEMALE; FEVER; HEALTH CARE UTILIZATION; HEMATURIA; HOSPITAL READMISSION; HOSPITALIZATION COST; HUMAN; HYPOPHAGIA; INFANT; INFANTILE TODDLER QUALITY OF LIFE QUESTIONNAIRE; INFLUENZA; INSOMNIA; INTENSIVE CARE; LENGTH OF STAY; LOOSE FECES; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL NEBULIZER; MULTICENTER STUDY; ORBIT CELLULITIS; OXYGEN DESATURATION; OXYGEN THERAPY; PARALLEL DESIGN; PNEUMONIA; PROTEINURIA; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SECONDARY INFECTION; SPHEROCYTOSIS; SYSTEMATIC REVIEW; SYSTOLIC HEART MURMUR; THORAX PAIN; THRUSH; UNITED KINGDOM; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VIRAL RESPIRATORY TRACT INFECTION; VIRUS INFECTION; VITAMIN DEFICIENCY; VOMITING; WHEEZING; COMBINATION DRUG THERAPY; COST BENEFIT ANALYSIS; ECONOMICS; INHALATIONAL DRUG ADMINISTRATION; MULTIMODALITY CANCER THERAPY; NEBULIZER; PROCEDURES; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

ACUTE DISEASE; ADMINISTRATION, INHALATION; ALBUTEROL; BRONCHIOLITIS; BRONCHODILATOR AGENTS; COMBINED MODALITY THERAPY; COST-BENEFIT ANALYSIS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT; LENGTH OF STAY; MALE; NEBULIZERS AND VAPORIZERS; OXYGEN INHALATION THERAPY; PATIENT READMISSION; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; SALINE SOLUTION, HYPERTONIC; SEVERITY OF ILLNESS INDEX; UNITED KINGDOM;

EID: 84940565017     PISSN: 13665278     EISSN: 20464924     Source Type: Journal    
DOI: 10.3310/hta19660     Document Type: Article

References (154)

1. Elliot S, Ray C. Viral Infections of the Lower Respiratory Tract. In Taussig L, Landau L, editors. Pediatric Respiratory Medicine. 2nd edn. Philadelphia, PA: Mosby Elsevier; 2009. pp. 481-90.
2. Everard M. Respiratory Syncytial Virus Bronchiolitis and Pneumonia. In Taussig L, Landau L, editors. Paediatric Respiratory Medicine. 2nd edn. St Louis, MO: Mosby; 2009. pp. 580-95.
3. Smyth RL, Openshaw PJM. Bronchiolitis. Lancet 2006; 368: 312-22. http://dx. doi. org/10. 1016/S0140-6736(06)69077-6.
4. Scottish Intercollegiate Guidelines Network (SIGN). Bronchiolitis in Children-A National Clinical Guideline. Edinburgh: SIGN; 2006. URL: www. sign. ac. uk/pdf/sign91. pdf (accessed 5 March 2014).
5. Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics 2006; 118: 1774-93. http://dx. doi. org/10. 1542/peds. 2006-2223.
6. Deshpande SA, Northern V. The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area. Arch Dis Child 2003; 88: 1065-9. http://dx. doi. org/10. 1136/adc. 88. 12. 1065.
7. Martin AJ, Gardner PS, Mcquillin J. Epidemiology of respiratory viral infection among paediatric inpatients over a six-year period in North-East England. Lancet 1978; 312: 1035-8. http://dx. doi. org/10. 1016/S0140-6736(78)92351-6.
8. Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009; 360: 588-98. http://dx. doi. org/10. 1056/NEJMoa0804877.
9. Murray J, Bottle A, Sharland M, Modi N, Aylin P, Majeed A, et al. Risk factors for hospital admission with RSV bronchiolitis in England: a population-based birth cohort study. Schildgen O, editor. PLOS ONE 2014; 9: e89186. http://dx. doi. org/10. 1371/journal. pone. 0089186.
10. Centers for Disease Control and Prevention (CDC). Respiratory Syncytial Virus Activity-United States, July 2008-December 2009. MMWR 2010: 59; 30-3. URL: www. cdc. gov/mmwr/preview/mmwrhtml/mm5908a4. htm (accessed 5 March 2014).
11. Fleming DM, Elliot AJ, Cross KW. Morbidity profiles of patients consulting during influenza and respiratory syncytial virus active periods. Epidemiol Infect 2007; 135: 1099-108. http://dx. doi. org/10. 1017/S0950268807007881.
12. Elliot AJ, Fleming DM. Influenza and respiratory syncytial virus in the elderly. Expert Rev Vaccines 2008; 7: 249-58. http://dx. doi. org/10. 1586/14760584. 7. 2. 249.
13. Falsey A, Hennessey P, Formica M, Cox C, Walsh E. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005; 352: 1749-59. http://dx. doi. org/10. 1056/NEJMoa043951.
14. Reynolds E, Cook C. The treatment of bronchiolitis. J Pediatr 1963; 63: 1205-7. http://dx. doi. org/10. 1016/S0022-3476(63)80215-2.
15. Panickar JR, Dodd SR, Smyth RL, Couriel JM. Trends in deaths from respiratory illness in children in England and Wales from 1968 to 2000. Thorax 2005; 60: 1035-8. http://dx. doi. org/10. 1136/thx. 2005. 044750.
16. Fleming DM, Pannell RS, Cross KW. Mortality in children from influenza and respiratory syncytial virus. J Epidemiol Community Health 2005; 59: 586-90. http://dx. doi. org/10. 1136/jech. 2004. 026450.
17. Health and Social Care Information Centre. Hospital Episode Statistics 2009-10. Leeds: Health and Social Care Information Centre; 2010. URL: www. hscic. gov. uk/pubs/hes0910 (accessed 1 April 2014).
18. Pelletier AJ, Mansbach JM, Camargo CA. Direct medical costs of bronchiolitis hospitalizations in the United States. Pediatrics 2006; 118: 2418-23. http://dx. doi. org/10. 1542/peds. 2006-1193.
19. Buckingham SC, Quasney MW, Bush AJ, DeVincenzo JP. Respiratory syncytial virus infections in the pediatric intensive care unit: clinical characteristics and risk factors for adverse outcomes. Pediatr Crit Care Med 2001; 2: 318-23. http://dx. doi. org/10. 1097/00130478-200110000-00006.
20. Thorburn K, Kerr S, Taylor N, van Saene HKF. RSV outbreak in a paediatric intensive care unit. J Hosp Infect 2004; 57: 194-201. http://dx. doi. org/10. 1016/j. jhin. 2004. 03. 013.
21. Sarrell EM, Tal G, Witzling M, Someck E, Houri S, Cohen HA, et al. Nebulized 3% hypertonic saline solution treatment in ambulatory children with viral bronchiolitis decreases symptoms. Chest 2002; 122: 2015-20. http://dx. doi. org/10. 1378/chest. 122. 6. 2015.
22. Mandelberg A, Tal G, Witzling M, Someck E, Houri S, Balin A, et al. Nebulized 3% hypertonic saline solution treatment in hospitalized infants with viral bronchiolitis. Chest 2003; 123: 481-7. http://dx. doi. org/10. 1378/chest. 123. 2. 481.
23. Tal G, Cesar K, Oron A, Houri S, Ballin A, Mandelberg A. Hypertonic saline/epinephrine treatment in hospitalized infants with viral bronchiolitis reduces hospitalization stay: 2 years experience. Isr Med Assoc J Imaj 2006; 8: 169-73.
24. Kuzik BA, Al-Qadhi SA, Kent S, Flavin MP, Hopman W, Hotte S, et al. Nebulized hypertonic saline in the treatment of viral bronchiolitis in infants. J Pediatr 2007; 151: 266-70. http://dx. doi. org/10. 1016/j. jpeds. 2007. 04. 010.
25. Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP. Nebulized hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev 2008; 4: CD006458. http://dx. doi. org/10. 1002/14651858. cd006458. pub2.
26. Mandelberg A, Amirav I. Hypertonic saline or high volume normal saline for viral bronchiolitis: mechanisms and rationale. Pediatr Pulmonol 2010; 45: 36-40. http://dx. doi. org/10. 1002/ppul. 21185.
27. Boogaard R, de Jongste JC, Merkus PJFM. Pharmacotherapy of impaired mucociliary clearance in non-CF pediatric lung disease. A review of the literature. Pediatr Pulmonol 2007; 42: 989-1001. http://dx. doi. org/10. 1002/ppul. 20693.
28. Gadomski AM, Bhasale A. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev 2006; 12: CD001266. http://dx. doi. org/10. 1002/14651858. cd001266. pub2.
29. Hartling L, Wiebe N, Russell K, Patel H, Klassen TP. Epinephrine for bronchiolitis. Cochrane Database Syst Rev 2004; 1: CD003123. http://dx. doi. org/10. 1002/14651858. cd003123. pub2.
30. Brooks LJ, Cropp GJ. Theophylline therapy in bronchiolitis. A retrospective study. Am J Dis Child 1981; 135: 934-6. http://dx. doi. org/10. 1001/archpedi. 1981. 02130340040014.
31. Everard M, Bara A, Kurian M, N'Diaye T, Ducharme F, Mayowe V. Anticholinergic drugs for wheeze in children under the age of two years. Cochrane Database Syst Rev 2005; 3: CD001279. http://dx. doi. org/10. 1002/14651858. cd001279. pub2.
32. Grewal S, Ali S, McConnell DW, Vandermeer B, Klassen TP. A randomized trial of nebulized 3% hypertonic saline with epinephrine in the treatment of acute bronchiolitis in the emergency department. Arch Pediatr Adolesc Med 2009; 163: 1007-12. http://dx. doi. org/10. 1001/archpediatrics. 2009. 196.
33. Anil AB, Anil M, Saglam AB, Cetin N, Bal A, Aksu N. High volume normal saline alone is as effective as nebulized salbutamol-normal saline, epinephrine-normal saline, and 3% saline in mild bronchiolitis. Pediatr Pulmonol 2010; 45: 41-7. http://dx. doi. org/10. 1002/ppul. 21108.
34. Everard ML. Acute bronchiolitis and croup. Pediatr Clin N Am 2009; 56: 119-33, x-xi. http://dx. doi. org/10. 1016/j. pcl. 2008. 10. 007.
35. Elphick H, Ritson S, Rigby A, Everard M. Phenotype of acute respiratory syncytial virus induced lower respiratory tract illness in infancy and subsequent morbidity. Acta Paediatr 2007; 96: 307-9. http://dx. doi. org/10. 1111/j. 1651-2227. 2007. 00082. x.
36. Plint AC, Osmond MH, Klassen TP. The efficacy of nebulized racemic epinephrine in children with acute asthma: a randomized, double-blind trial. Acad Emerg Med 2000; 7: 1097-103. http://dx. doi. org/10. 1111/j. 1553-2712. 2000. tb01258. x.
37. Hartling L, Wiebe N, Russell K, Patel H, Klassen TP. A meta-analysis of randomized controlled trials evaluating the efficacy of epinephrine for the treatment of acute viral bronchiolitis. Arch Pediatr Adolesc Med 2003; 157: 957-64. http://dx. doi. org/10. 1001/archpedi. 157. 10. 957.
38. Wainwright C, Altamirano L, Cheney M, Cheney J, Barber S, Price D, et al. A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis. N Engl J Med 2003; 349: 27-35. http://dx. doi. org/10. 1056/NEJMoa022226.
39. Hariprakash S, Alexander J, Carroll W, Ramesh P, Randell T, Turnbull F, et al. Randomized controlled trial of nebulized adrenaline in acute bronchiolitis. Pediatr Allergy Immunol 2003; 14: 134-9. http://dx. doi. org/10. 1034/j. 1399-3038. 2003. 00014. x.
40. Cade A, Brownlee KG, Conway SP, Haigh D, Short A, Brown J, et al. Randomised placebo controlled trial of nebulised corticosteroids in acute respiratory syncytial viral bronchiolitis. Arch Dis Child 2000; 82: 126-30. http://dx. doi. org/10. 1136/adc. 82. 2. 126.
41. Everard M, Swarbrick A, Rigby A, Milner A. The effect of ribavirin to treat previously healthy infants admitted with acute bronchiolitis on acute and chronic respiratory morbidity. Respir Med 2001; 95: 275-80. http://dx. doi. org/10. 1053/rmed. 2001. 1033.
42. Everard ML. The role of the respiratory syncytial virus in airway syndromes in childhood. Curr Allergy Asthma Rep 2006; 6: 97-102. http://dx. doi. org/10. 1007/s11882-006-0046-z.
43. Calogero C, Sly PD. Acute viral bronchiolitis: to treat or not to treat-that is the question. J Pediatr 2007; 151: 235-7. http://dx. doi. org/10. 1016/j. jpeds. 2007. 05. 041.
44. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340: 1-28. http://dx. doi. org/10. 1136/bmj. c869.
45. Great Britain. The Medicines for Human Use (Clinical Trials) Regulations 2004. No. 1038. Statutory Instruments; 2004.
46. Raat H, Landgraf J, Oostenbrink R, Moll H, Essink-bot M. Reliability and validity of the Infant and Toddler Quality of Life Questionnaire (ITQOL) in a general population and respiratory disease sample. Qual Life Res 2007; 16: 445-60. http://dx. doi. org/10. 1007/s11136-006-9134-8.
47. Behrendt CE, Decker MD, Burch DJ, Watson PH. International variation in the management of infants hospitalized with respiratory syncytial virus. International RSV Study Group. Eur J Pediatr 1998; 157: 215-20. http://dx. doi. org/10. 1007/s004310050798.
48. Elashoff J, Reedy T. Two-stage clinical trial stopping rules. Biometrics 1984; 40: 791-5. http://dx. doi. org/10. 2307/2530923.
49. Perrotta C, Ortiz Z, Roque M. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database Syst Rev 2005; 2: CD004873. http://dx. doi. org/10. 1002/14651858. cd004873. pub2.
50. Therneau TM, Grambsch P. Modeling Survival Data: Extending the Cox Model. New York, NY: Springer-Verlag; 2000. http://dx. doi. org/10. 1007/978-1-4757-3294-8.
51. Joint Formulary Committee. British National Formulary. 65 edn. London: BMJ Group and Pharmaceutical Press; 2013.
52. Department of Health (DH). NHS Reference Costs 2013. London: DH; 2013.
53. Curtis L. Unit Costs of Health and Social Care 2013. Canterbury: PSSRU, University of Kent; 2013.
54. Turner J, O'Cathain A, Knowles E, Nicholl J, Tosh J, Sampson F, et al. Evaluation of NHS 111 pilot sites. Sheffield: University of Sheffield, School of Health and Related research (ScHARR); 2012. URL: www. shef. ac. uk/polopoly_fs/1. 227404!/file/NHS_111_final_report_August_2012. pdf (accessed 19 May 2014).
55. Carroll AE, Downs SM. Improving decision analyses: parent preferences (utility values) for pediatric health outcomes. J Pediatr 2009; 155: 21-5. http://dx. doi. org/10. 1016/j. jpeds. 2009. 01. 040.
56. Ara R, Wailoo A. The Use of Health State Utility Values in Decision Models. NICE Decision Support Unit Technical Support Document 12. Sheffield: University of Sheffield, School of Health and Related Research (ScHARR). 2011. URL: www. nicedsu. org. uk/TSD12 Utilities in modelling FINAL. pdf (accessed 19 May 2014).
57. Saigal S, Feeny D, Furlong W, Rosenbaum P, Burrows E, Torrance G. Comparison of the health-related quality of life of extremely low birth weight children and a reference group of children at age eight years. J Pediatr 1994; 125: 418-25. http://dx. doi. org/10. 1016/S0022-3476(05)83289-5.
58. Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP. Nebulised hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev 2013; 7: CD006458. http://dx. doi. org/10. 1002/14651858. cd006458. pub3.
59. Liu J, Qiao B, Ma C, Zhang D, Zhang J. Treatment of bronchiolitis with inhaled nebulized hypertonic saline solution combined with budesonide. J Clin Pediatr 2013; 31: 440-2.
60. Zhang GJ. Observation of the effects of 4. 3% hypertonic saline and compound ipratropium bromide inhalation in treating bronchiolitis. Chinese J Med Guid 2013; 10.
61. Zhou Y, Lu YD, Tan XJ, Zhang CP. Impact of hypertonic saline combined with salbutamol inhalation on the infectious bronchiolitis. China Med 2013; 8.
62. Wang H. The mechanism of nebulized drugs in the treatment of patients with exacerbation of bronchiolitis. Int J Pediatr 2013: 450-3.
63. Zhang Y. Clinical effects and safety of hypertonic saline combined with budesonide via aerosol inhalation in treatment of bronchiolitis. Anhui Med J 2013; 34: 1333-5.
64. Ramilo O, Mejias A. Novedades en el tratamiento de la bronquiolitis: perpectivas en el 2013. An Pediatr 2013; 78: 205-7. http://dx. doi. org/10. 1016/j. anpedi. 2013. 02. 017.
65. Nüßlein T. Hypertone Salzlösung zur Inhalation bei akutem Giemen im Vorschulalter. Der Pneumol 2014; 11: 171-2. http://dx. doi. org/10. 1007/s10405-014-0778-8.
66. Xu J. Cost-effectiveness analysis of hypertonic saline combined with low-dose budesonide inhalation in mild to moderate bronchiolitis. J Pediatr Pharm 2013; 19: 38-40.
67. Li G, Jing Z. [Effectiveness of inhaled hypertonic saline in children with bronchiolitis. ] Chinese J Pediatr 2014; 52: 607-10.
68. Park JY, Jeong YM, Jeong SJ, Seo SS. The efficacy of nebulized 3 percent hypertonic saline solution and fenoterol in infants with bronchiolitis. Korean J Pediatr 2005; 48: 518-22.
69. Zheng W, Li L, Chengfung H, Yunmei H, Wei L. The effects of high frequency inhalation of the 3% hypertonic saline solution with ambroxol hydrochloride in the treatment of 43 bronchiolitis patients. J Pediatr Pharm 2012; 18: 19-21.
70. Centre for Reviews and Dissemination (CRD). Systematic Reviews: CRD's Guidance for Undertaking Reviews in Health Care. York: University of York; 2009. URL: www. york. ac. uk/inst/crd/pdf/Systematic_Reviews. pdf (accessed 7 February 2014).
71. Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP. Nebulized hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev 2009; 4: CD006458. http://dx. doi. org/10. 1002/14651858. CD006458. pub2.
72. Papaioannou D, Sutton A, Carroll C, Booth A, Wong R. Literature searching for social science systematic reviews: consideration of a range of search techniques. Health Info Libr J 2010; 27: 114-22. http://dx. doi. org/10. 1111/j. 1471-1842. 2009. 00863. x.
73. Schlosser RW, Wendt O, Bhavnani S, Nail-Chiwetalu B. Use of information-seeking strategies for developing systematic reviews and engaging in evidence-based practice: the application of traditional and comprehensive Pearl Growing. A review. Int J Lang Commun Disord 2006; 41: 567-82. http://dx. doi. org/10. 1080/13682820600742190.
74. Espelt M. Efficacy of Nebulized Hypertonic Saline in the Treatment of Acute Bronchiolitis (NCT01238848). ClinicalTrials. gov: 2012. URL: www. clinicaltrials. gov/ct2/show/NCT01238848? term=espelt+bronchiolitis&rank=1 (accessed 31 January 2014).
75. Sosa-Bustamante GP. Nebulized 3% Hypertonic Saline Solution Treatment of Bronchiolitis in Infants (NCT02233985). ClinicalTrials. gov: 2014. URL: https://clinicaltrials. gov/ct2/show/study/NCT02233985?term="Hypertonic+saline"+AND+"bronchiolitis"&lup_s=01/03/2014&rank=8 (accessed 19 January 2015).
76. Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions. 5. 1. 0 edn. London: Cochrane; 2011 [updated March 2011]. URL: www. cochrane-handbook. org (accessed 31 January 2014).
77. Giudice M, Saitta F, Leonardi S, Capasso M, Niglio B, Chinellato I, et al. Effectiveness of nebulized hypertonic saline and epinephrine in hospitalized infants with bronchiolitis. Int J Immunopathol Pharmacol 2012; 25: 485-91.
78. Wang EE, Milner RA, Navas L, Maj H. Observer agreement for respiratory signs and oximetry in infants hospitalized with lower respiratory infections. Am Rev Respir Dis 1992; 145: 106-9. http://dx. doi. org/10. 1164/ajrccm/145. 1. 106.
79. Luo Z, Liu E, Luo J, Li S, Zeng F, Yang X, et al. Nebulized hypertonic saline/salbutamol solution treatment in hospitalized children with mild to moderate bronchiolitis. Pediatr Int 2010; 52: 199-202. http://dx. doi. org/10. 1111/j. 1442-200X. 2009. 02941. x.
80. Luo Z, Fu Z, Liu E, Xu X, Fu X, Peng D, et al. Nebulized hypertonic saline treatment in hospitalized children with moderate to severe viral bronchiolitis. Clin Microbiol Infect Off Eur Soc Clin Microbiol Infect 2011; 17: 1829-33. http://dx. doi. org/10. 1111/j. 1469-0691. 2010. 03304. x.
81. Maheshkumar KB, Karunakara BP, Nagalli MM, Mallikarjuna HB. Aerosolised hypertonic saline in hospitalized young children with acute bronchiolitis: a randomized controlled clinical trial. J Pediatr Sci 2013; 5: e174.
82. Sharma BS, Gupta MK, Rafik SP. Hypertonic (3%) saline vs 0. 9% saline nebulization for acute viral bronchiolitis: a randomized controlled trial. Indian Pediatr 2013; 50: 743-7. http://dx. doi. org/10. 1007/s13312-013-0216-8.
83. Al-Ansari K, Sakran M, Davidson BL, El SR, Mahjoub H, Ibrahim K. Nebulized 5% or 3% hypertonic or 0. 9% saline for treating acute bronchiolitis in infants. J Pediatr 2010; 157: 630-4. http://dx. doi. org/10. 1016/j. jpeds. 2010. 04. 074.
84. Nemsadze K, Chkhaidze I, Kiknadze N. Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis in Infants. Barcelona: ERS Congress Abstract; 2013. p. 412. URL: www. ersnet. org/learning_resources_player/abstract_print_13/files/Abstract_book_2013. pdf (accessed 15 April 2014).
85. Pandit S, Dhawan N, Thakur D. Utility of hypertonic saline in the management of acute bronchiolitis in infants: a randomised controlled study. Int J Clin Pediatr 2013; 2: 24-9. http://dx. doi. org/10. 4021/ijcp96w.
86. Teunissen J, Hochs AHJ, Vaessen-Verberne A, Boehmer ALM, Smeets CCJM, Brackel H, et al. The effect of 3% and 6% hypertonic saline in viral bronchiolitis: a randomised controlled trial. Eur Respir J 2014; 44: 913-21. http://dx. doi. org/10. 1183/09031936. 00159613.
87. Everard ML, Hind D, Ugonna K, Freeman J, Bradburn M, Cooper CL, et al. SABRE: a multicentre randomised control trial of nebulised hypertonic saline in infants hospitalised with acute bronchiolitis. Thorax 2014; 69: 1105-12. http://dx. doi. org/10. 1136/thoraxjnl-2014-205953.
88. Silver A. A Study of Hypertonic Saline for Infants Hospitalized With Bronchiolitis (NCT01488448). ClinicalTrials. gov: 2014. URL: https://clinicaltrials. gov/ct2/show/NCT01488448 (accessed 19 January 2015).
89. Ozdogan S, Koker O, Kose G, Yildirmak Y. The efficacy of nebulized hypertonic saline in acute bronchiolitis in hospital setting: a randomized and double blind trial. AmJ Resp Crit Care Med 2014; 189: A2740.
90. Ojha A, Mathema S, Sah S, Aryal U. A comparative study on use of 3% saline versus 0. 9% saline nebulisation in children with bronchiolitis. J Nepal Heal Res Counc 2014; 12: 39-43.
91. Hartling L, Ospina M, Liang Y, Dryden DM, Hooton N, Krebs Seida J, et al. Risk of bias versus quality assessment of randomised controlled trials: cross sectional study. BMJ 2009; 339: b4012. http://dx. doi. org/10. 1136/bmj. b4012.
92. Egger M, Davey Smith G, Altman DG. Systematic Reviews in Health Care: Meta-Analysis in Context. 2nd edn. London: BMJ Publishing Group; 2001. http://dx. doi. org/10. 1002/9780470693926.
93. Kirkham JJ, Dwan KM, Altman DG, Gamble C, Dodd S, Smyth R, et al. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 2010; 340: c365. http://dx. doi. org/10. 1136/bmj. c365.
94. Sterne JAC, Egger M, Smith GD. Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. BMJ 2001; 323: 101-5. http://dx. doi. org/10. 1136/bmj. 323. 7304. 101.
95. Dwan K, Gamble C, Kolamunnage-Dona R, Mohammed S, Powell C, Williamson PR. Assessing the potential for outcome reporting bias in a review: a tutorial. Trials 2010; 11: 52. http://dx. doi. org/10. 1186/1745-6215-11-52.
96. National Institute for Health and Care Research (NICE). Guide to the Methods of Technology Appraisal 2013. London: NICE; 2013. URL: http://www. nice. org. uk/article/pmg9/chapter/foreword (accessed 17 December 2014).
97. Kuzik BA, Flavin MP, Kent S, Zielinski D, Kwan CW, Adeleye A, et al. Effect of inhaled hypertonic saline on hospital admission rate in children with viral bronchiolitis: a randomized trial. CJEM 2010; 12: 477-84.
98. Sezer GR, Bozaykut A, Ipek IO, Uyur E, Seren PL, Paketci C. The efficacy of nebulized salbutamol, hypertonic saline and salbutamol/hypertonic saline combination in first bronchiolitis attack. Acta Paediatr 2010; 99: 153. http://dx. doi. org/10. 1016/j. pupt. 2011. 09. 004.
99. Jacobs JD, Foster M, Wan J, Pershad J. 7% Hypertonic saline in acute bronchiolitis: a randomized controlled trial. Pediatrics 2014; 133: e8-13. http://dx. doi. org/10. 1542/peds. 2013-1646.
100. Wu S, Baker C, Lang ME, Schrager SM, Liley FF, Papa C, et al. Nebulized hypertonic saline for bronchiolitis: a randomized clinical trial. JAMA Pediatrics 2014; 168: 657-63. http://dx. doi. org/10. 1001/jamapediatrics. 2014. 301.
101. Ipek IO, Yalcin EU, Sezer RG, Bozaykut A. The efficacy of nebulized salbutamol, hypertonic saline and salbutamol/hypertonic saline combination in moderate bronchiolitis. Pulm Pharmacol Ther 2011; 24: 633-7. http://dx. doi. org/10. 1016/j. pupt. 2011. 09. 004.
102. Gupta N, Puliyel A, Manchanda A, Puliyel J. Nebulized hypertonic-saline vs epinephrine for bronchiolitis: proof of concept study of cumulative sum (CUSUM) analysis. Indian Pediatr 2012; 49: 543-7. http://dx. doi. org/10. 1007/s13312-012-0122-5.
103. Khashabi J, Salari LS, Karamiyar M, Mussavi H. Comparison of the efficacy of nebulized L-epinephrine, salbutamol and normal saline in acute bronchiolitis: a randomized clinical trial. Med J Islam Repub Iran 2005; 19: 119-25.
104. Lines DR, Bates ML, Rechtman AR, Sammartino LP. Efficacy of nebulised ipratropium bromide in acute bronchiolitis. Pediatr Rev Commun 1992; 6: 161-7.
105. Milner A. [The role of anticholinergic in acute bronchiolitis in infancy. ] Arch Pediatr 1995; 2(Suppl. 2): 159-62. http://dx. doi. org/10. 1016/0929-693X(96)89885-X.
106. Patel H, Platt RW, Pekeles GS, Ducharme FM. A randomized, controlled trial of the effectiveness of nebulized therapy with epinephrine compared with albuterol and saline in infants hospitalized for acute viral bronchiolitis. J Pediatr 2002; 141: 818-24. http://dx. doi. org/10. 1067/mpd. 2002. 129844.
107. Tinsa F, Rhouma AB, Ghaffari H, Boussetta K, Zouari B, Brini I, et al. A randomized, controlled trial of nebulized terbutaline for the first acute bronchiolitis in infants less than 12 months old. Tunis Med 2009; 87: 200-3.
108. Postiaux G, Louis J, Labasse HC, Gerroldt J, Kotik AC, Lemuhot A, et al. Evaluation of an alternative chest physiotherapy method in infants with respiratory syncytial virus bronchiolitis. Respir Care 2011; 56: 989-94. http://dx. doi. org/10. 4187/respcare. 00721.
109. Chowdhury D, al HM, Khalil M, al-Frayh AS, Chowdhury S, Ramia S. The role of bronchodilators in the management of bronchiolitis: a clinical trial. Ann Trop Paediatr 1995; 15: 77-84.
110. Nenna R, Tromba V, Berardi R, De AD, Papoff P, Sabbatino G, et al. Recombinant human deoxyribonuclease treatment in hospital management of infants with moderate-severe bronchiolitis. Eur J Inflamm 2009; 7: 169-74.
111. Bertrand P, Aranibar H, Castro E, Sanchez I. Efficacy of nebulized epinephrine versus salbutamol in hospitalized infants with bronchiolitis. Pediatr Pulmonol 2001; 31: 284-8. http://dx. doi. org/10. 1002/ppul. 1040.
112. Nenna R, Papoff P, Moretti C, De Angelis D, Battaglia M, Papasso S, et al. Seven percent hypertonic saline-0. 1% hyaluronic acid in infants with mild-to-moderate bronchiolitis. Pediatr Pulmonol 2013; 46: 919-25. http://dx. doi. org/10. 1002/ppul. 22935.
113. Bueno Campaña M, Olivares Ortiz J, Notario Muñoz C, Rupérez Lucas M, Fernández Rincón A, Patiño Hernández O, et al. High flow therapy versus hypertonic saline in bronchiolitis: randomised controlled trial. Arch Dis Child 2014; 12: 1-5. http://dx. doi. org/10. 1136/archdischild-2013-305443.
114. Mandelberg A. Hypertonic saline in the treatment of acute bronchiolitis in the emergency department. Arch Pediatr Adolesc Med 2010; 164: 395-7. http://dx. doi. org/10. 1001/archpediatrics. 2010. 37.
115. Principi T, Komar L. A critical review of 'a randomized trial of nebulized 3% hypertonic saline with epinephrine in the treatment of acute bronchiolitis in the emergency department.' J Popul Ther Clin Pharmacol 2011; 18: e273-4.
116. Hom J, Fernandes RM. When should nebulized hypertonic saline solution be used in the treatment of bronchiolitis? Paediatr Child Health (Oxford) 2011; 16: 157-8.
117. Sauvaget E, David M, Bresson V, Retornaz K, Bosdure E, Dubus JC. [Nebulized hypertonic saline and acute viral bronchiolitis in infants: current aspects. ] Arch Pediatr 2012; 19: 635-41. http://dx. doi. org/10. 1016/j. arcped. 2012. 03. 018.
118. Lowell DI, Lister G, Von Koss H, McCarthy P. Wheezing in infants: the response to epinephrine. Pediatrics 1987; 79: 939-45.
119. Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 2001; 135: 982-9. http://dx. doi. org/10. 7326/0003-4819-135-11-200112040-00010.
120. Poole C, Greenland S. Random-effects meta-analyses are not always conservative. Am J Epidemiol 1999; 150: 469-75. http://dx. doi. org/10. 1093/oxfordjournals. aje. a010035.
121. Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 2001; 54: 1046-55. http://dx. doi. org/10. 1016/S0895-4356(01)00377-8.
122. Vickers A, Goyal N, Harland R, Rees R. Do certain countries produce only positive results? A systematic review of controlled trials. Control Clin Trials 1998; 19: 159-66. http://dx. doi. org/10. 1016/S0197-2456(97)00150-5.
123. Egger M, Juni P, Bartlett C, Holenstein F, Sterne J. How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. Health Technol Assess 2003; 7(1).
124. Smith V, Devane D, Begley CM, Clarke M. Methodology in conducting a systematic review of systematic reviews of healthcare interventions. BMC Med Res Methodol 2011; 11: 15. http://dx. doi. org/10. 1186/1471-2288-11-15.
125. Morrison A, Polisena J, Husereau D, Moulton K, Clark M, Fiander M, et al. The effect of English-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies. Int J Technol Assess Health Care 2012; 28: 138-44. http://dx. doi. org/10. 1017/S0266462312000086.
126. Thompson SG, Higgins JPT. How should meta-regression analyses be undertaken and interpreted? Stat Med 2002; 21: 1559-73. http://dx. doi. org/10. 1002/sim. 1187.
127. Senn S. Some controversies in planning and analysing multi-centre trials. Stat Med 17: 1753-65; discussion 1799-800.
128. Petitti D. Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis. Medicine: Methods for Quantitative Synthesis in Medicine. Oxford: Oxford University Press; 1999. http://dx. doi. org/10. 1093/acprof: oso/9780195133646. 001. 0001.
129. Moreno SG, Sutton AJ, Thompson JR, Ades AE, Abrams KR, Cooper NJ. A generalized weighting regression-derived meta-analysis estimator robust to small-study effects and heterogeneity. Stat Med 2012; 31: 1407-17. http://dx. doi. org/10. 1002/sim. 4488.
130. Teunissen J, Hochs A, Vaessen-Verberne AAP, Boehmer ALM, Smeets C, Brackel H, et al. Effect of Inhaled Hypertonic Saline Solution to Treat Infants Hospitalized with Viral Bronchiolitis. ERS Congress Abstract. 2011. pp. 293-4. URL: www. ers-education. org/ersMade/abstract_print_11/files/Abstract_book_2011. pdf (accessed 15 April 2014).
131. Elphick H, Everard M. Noisy Breathing in Children. In David T, editor. Recent Advances in Paediatrics. London: The Royal Society of Medicine; 2002.
132. Elphick H, Ritson S, Rodgers H, Everard M. When a 'wheeze' is not a wheeze: acoustic analysis of breath sounds in infants. Eur Respir J 2000; 16: 593-7. http://dx. doi. org/10. 1034/j. 1399-3003. 2000. 16d04. x.
133. Elphick HE, Lancaster GA, Solis A, Majumdar A, Gupta R, Smyth RL. Validity and reliability of acoustic analysis of respiratory sounds in infants. Arch Dis Child 2004; 89: 1059-63. http://dx. doi. org/10. 1136/adc. 2003. 046458.
134. Pasterkamp H. Nomenclature used by health care professionals to describe breath sounds in asthma. Chest J 1987; 92: 346. http://dx. doi. org/10. 1378/chest. 92. 2. 346.
135. Spiteri MA, Cook DG, Clarke SW. Reliability of eliciting physical signs in examination of the chest. Lancet 1988; 1: 873-5. http://dx. doi. org/10. 1016/S0140-6736(88)91613-3.
136. American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics 2006; 118: 1774-93. URL: http://www. ncbi. nlm. nih. gov/pubmed/17015575 (accessed 21 February 2014).
137. http://dx. doi. org/10. 1542/peds. 2006-2223.
138. Bisgaard H, Flores-Nunez A, Goh A, Azimi P, Halkas A, Malice M-P, et al. Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children. Am J Respir Crit Care Med 2008; 178: 854-60. http://dx. doi. org/10. 1164/rccm. 200706-910OC.
139. Rosenthal R. The file drawer problem and tolerance for null results. Psychol Bull 1979; 86: 638-41. http://dx. doi. org/10. 1037/0033-2909. 86. 3. 638.
140. Cunningham S, McIntosh E, Lewis S. Effect of accepting lower oxygen saturation target (90%) on recovery from acute viral bronchiolitis (BIDS Trial): a multi-centre double-blind randomised equivalence trial. Am J Respir Crit Care Med 2014; 189: A4690. http://dx. doi. org/10. 1136/archdischild-2014-306237. 90.
141. Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA 1990; 263: 1385-9. http://dx. doi. org/10. 1001/jama. 1990. 03440100097014.
142. Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP. Nebulised hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev 2013; 7: CD006458. http://dx. doi. org/10. 1002/14651858. cd006458. pub3.
143. Turner RM, Davey J, Clarke MJ, Thompson SG, Higgins JPT. Predicting the Extent of Heterogeneity in Meta-analysis, Using Empirical Data from the Cochrane Database of Systematic Reviews. Oxford: Oxford University Press; 2012. URL: http://ije. oxfordjournals. org/content/early/2012/03/28/ije. dys041/T3. expansion. html (accessed 15 July 2014).
144. Ziegler A. [Clear redundancy in meta-analyses-overlapping meta-analyses can absolutely be useful. ] Dtsch Med Wochenschr 2013; 138: 2080. http://dx. doi. org/10. 1055/s-0032-1329061.
145. Linden W. How many meta-analyses does it take to settle a question? Psychosom Med 2013; 75: 332-4. http://dx. doi. org/10. 1097/PSY. 0b013e318295e046.
146. Moher D. The problem of duplicate systematic reviews. BMJ 2013; 347: f5040. http://dx. doi. org/10. 1136/bmj. f5040.
147. PARI Medical Ltd. MucoClear 3% Information. URL: www. parimedical. co. uk/products/pari_saline_solutions/product/detail/info/mucoclear_3_20_ampoules-1. html (accessed 15 April 2014).
148. Gargon E, Williamson PR, Altman DG, Blazeby JM, Clarke M. The COMET Initiative database: progress and activities from 2011 to 2013. Trials. 2014; 15: 279. http://dx. doi. org/10. 1186/1745-6215-15-279.
149. Van Miert C, Abbott J, Verheoff F, Lane S, Carter B, McNamara P. Development and validation of the Liverpool infant bronchiolitis severity score: a research protocol. J Adv Nurs 2014; 70: 2353-62. http://dx. doi. org/10. 1111/jan. 12387.
150. Mayfield S, Bogossian F, O'Malley L, Schibler A. High-flow nasal cannula oxygen therapy for infants with bronchiolitis: pilot study. J Paediatr Child Health 2014; 50: 373-8. http://dx. doi. org/10. 1111/jpc. 12509.
151. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for human use (ICH). ICH Harmonised Tripartite Guideline: Statistical Principles for Clinical Trials E9. Geneva: ICH; 2010.
152. DAMOCLES Study Group. A proposed charter for clinical trial data monitoring committees: helping them to do their job well. Lancet 2005; 365: 711-22. http://dx. doi. org/10. 1016/S0140-6736(05)70939-9.
153. SAS Institute Inc. SAS 9. 1. 3 Help and Documentation. Cary, NC: SAS Institute Inc.; 2007.
154. Borenstein M, Hedges L, Rothstein H. Meta-Analysis Fixed Effect vs Random Effects. 2010. URL: www. meta-analysis. com/downloads/Meta-analysis fixed effect vs random effects. pdf (accessed 31 January 2014).